Healthcare
Wise wholly acquires PH&T for €15m
Italian pharmaceutical company to undertake buy-and-build growth strategy
Cinven sells 10% stake in Spire Healthcare for £126.3m
Listed private hospital operator floated with market cap of £842m last year
Seroba et al. invest £18m in Veryan
Company plans on commercialising its product later this year
Sunstone et al in €20m series-B for Orphazyme
Total funding for Orphazyme reaches €34m with latest round
Gimv’s Almaviva bolts on Paris hospital
Bolt-on increases Almaviva's 2014 revenues to €130m
SV et al. sell Convergence for $675m
VCs invested in the company in 2010
DFJ et al. in £1.56m series-A for Fluidic Analytics
Cambridge biotech company set to launch its products
Thuja et al. invest in Hemics
Company plans to commercialise HandScan product
3i-backed OneMed acquires Bosman Medical Devices
Acquisition will support OneMed's international growth and expand product range
Apposite's Convergence sold to Biogen Idec in $475m deal
GP took part in $35.4m series-A for biopharmaceutical company in 2010
Seventure backs MaaT
Firm commits to invest further €1m based on milestones
Fountain Healthcare launches second fund
Fund will invest primarly in European healthcare
Miracor raises €4.5m series-B extension
€7m series-B took place in September 2011
Verdane sells CRF Health to Vitruvian
Exit comes two years after company was acquired in direct secondary
NeoMed leads CHF 20m Genkyotex financing
VI Partners and BioMedInvest are co-investors
SHS et al. invest in Vimecon
Existing and new investors also committed to latest funding round
LDC-backed Prism bolts on TMEC
Deal is second acquisition by medical equipment company with LDC
Terra Firma’s Four Seasons negotiates profits covenant waiver
GP bought the company for £825m almost three years ago
Sovereign acquires Nurse Plus from KCP
Deal marks an exit for KCP after just two and a half years
Oxford Tech in £2m round for Lightpoint
Several business angel networks also participated in the round
Waterland merges Median and RHM
GP acquired Median earlier this year for €1bn
MIG takes part in €10m round for Protagen
Diagnostic tool developer to bring IVD development programmes to market
Versant closes fund on $305m, makes European promotions
Principal Tom Woiwode has been promoted to managing director in firm's Basel office
Thuja et al. invest €6m in Cristal
Company will use funds to launch first clinical study of anti-cancer nanomedicine